Minnelide free acid
Product Specifications
CAS Number
1254885-39-6
Target
Apoptosis, Others
Related Pathways
Apoptosis, Others
Bioactivity
Minnelide is an effective therapy against pancreatic cancer. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants. Minnelide reduced tumor volume in multiple models of pancreatic cancer. Minnelide was a more effective drug against pancreatic cancer models. It effectively reduced tumor burden and tumor related morbidity in different unique but complementary mouse models. It reduced metastatic spread and increased survival in the different models as well.
Smiles
C[C@@]12[C@@]34[C@]5([C@H](OCOP(=O)(O)O)[C@]6(C(C)C)[C@]([C@@]3(O4)[H])(O6)[H])[C@@](O5)(C[C@]1(C7=C(CC2)C(=O)OC7)[H])[H]
Molecular Formula
C21H27O10P
Molecular Weight
470.41
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1410598-01 0.02 mg (E-Coli)
Recombinant Helicobacter hepaticus Queuine tRNA-ribosyltransferase (tgt)
Sign In for Pricing
View Details MBS1410598-02 0.02 mg (Yeast)
Recombinant Helicobacter hepaticus Queuine tRNA-ribosyltransferase (tgt)
Sign In for Pricing
View Details MBS1410598-03 0.1 mg (E-Coli)
Recombinant Helicobacter hepaticus Queuine tRNA-ribosyltransferase (tgt)
Sign In for Pricing
View Details MBS1410598-04 0.1 mg (Yeast)
Recombinant Helicobacter hepaticus Queuine tRNA-ribosyltransferase (tgt)
Sign In for Pricing
View Details MBS1410598-05 0.02 mg (Baculovirus)
Recombinant Helicobacter hepaticus Queuine tRNA-ribosyltransferase (tgt)
Sign In for Pricing
View Details